Sepetaprost

司培前列素

Report date: 2026/01/30 17:56:47
NME

Base Information

Drug NameSepetaprost
Drug Alias NameSepetaprostum塞他前列素セタネオSETANEOSTN1012600 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid EP3 receptor agonistsProstanoid FP receptor agonists
TargetsProstanoid FP receptorProstanoid EP3 receptor
Therapy Area/IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Global Approved IndicationsGlaucomaOcular Hypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2025/08/25
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOno Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSanten IncSanten Pharmaceutical Co LtdSanten
Inactive CompaniesOno Pharmaceutical Co LtdOno Pharma Usa Inc
Active IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank